This inventor holds 1 USPTO granted patent. Top assignee: Orion Corporation. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Mikhail Ruda: Innovator in Cardiac Treatment
Introduction
Mikhail Ruda is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of medicine, particularly in the treatment of cardiac conditions. His innovative approach has led to the development of a unique method for treating sick sinus syndrome.
Latest Patents
Mikhail Ruda holds a patent for a method of treating sick sinus syndrome with levosimendan. The patent describes levosimendan, or (−)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]propanedinitrile, which has been previously suggested for the treatment of congestive heart failure. This compound is now recognized for its utility in treating sick sinus syndrome and/or sinoatrial conduction disorders. He has 1 patent to his name.
Career Highlights
Mikhail Ruda is associated with Orion Corporation, where he continues to work on innovative solutions in cardiac care. His research and development efforts have positioned him as a key figure in the medical community.
Collaborations
Mikhail has collaborated with notable professionals in his field, including Lasse Lehtonen and Jeffrey Hosenpud. These partnerships have enhanced his research and contributed to the advancement of cardiac treatment methodologies.
Conclusion
Mikhail Ruda's contributions to the treatment of sick sinus syndrome highlight his innovative spirit and dedication to improving patient care. His work continues to influence the medical field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile